Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges

Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges

Glucagon-like peptide-1 (GLP-1) receptor agonists (GRA) belong to a class of compounds that reduce blood glucose and energy intake by simulating actions of endogenous incretin hormone GLP-1 after it is released by the gut following food consumption. They are used to treat type 2 diabetes mellitus (T...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhi Dong Zhou, Lingxiao Yi, Karolina Popławska-Domaszewicz, Kallol Ray Chaudhuri, Joseph Jankovic, Eng King Tan
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Pharmacological Research
Subjects:
Glucagon-like peptide-1
GLP-1 receptor agonists
Neurodegenerative diseases
Alzheimer’s disease
Parkinsons' disease
Type 2 diabetes mellitus
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661825001951
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1043661825001951

Similar Items